Proteolysis-targeting chimeras (PROTACs) and molecular glue degraders (MGDs) are quite possibly the most maturely formulated TPD strategies. During this overview, we focus on equally preclinical experiments and scientific trials to provide an extensive summary of the safety and scientific usefulness of PROTACs and MGDs in hematologic malignancies in the last https://paxtonzfjqu.csublogs.com/38375191/the-md-224-diaries